Board Performance · 2025
In this section14 topics
- Compliance Monitoring — Overview1 item
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives5 items
- Selection of Independent Directors2 items
- Evaluation of Board & Subcommittee Performance2 items
- Subcommittees1 item
- Meeting Attendance & Remuneration3 items
- Supervision of Subsidiaries & Associated Companies5 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Compliance Monitoring — Overview
Monitoring of Compliance with Other CG Policies & Guidelines
Anti-Corruption
Implementation of Anti-Corruption Measures During the Past Year
The Company has reviewed the appropriateness of its anti-corruption measures, communicated and provided training to employees regarding the anti-corruption policy and guidelines, monitored and evaluated compliance with the anti-corruption policy, and conducted reviews to ensure completeness and effectiveness.
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The company has established a policy for related-party transactions to ensure that the terms and conditions are in line with normal business operations and market prices, comparable to those offered to external parties. All transactions must strictly adhere to agreed-upon contracts, and prices and terms must be clearly defined, fair, and free from any transfer of benefits. The internal audit department will regularly review information and prepare reports for the audit committee to consider and provide feedback on the appropriateness and reasonableness of the prices and transactions on a quarterly basis.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The company monitors and manages potential conflicts of interest between the company and management, the board of directors, or shareholders, including preventing the misuse of company assets, information, and opportunities, and conducting inappropriate transactions with related parties. The company will oversee its information security system, including policies and procedures for confidentiality, integrity, and availability of information, as well as managing market-sensitive information that may affect securities prices. Furthermore, the company will ensure that its directors, senior executives, employees, and related external parties, such as legal and financial advisors, comply with the information security system. The company will oversee the management and monitoring of transactions that may involve conflicts of interest, and ensure that guidelines and procedures are in place to guarantee that such transactions comply with legal requirements and disclosures, and are conducted in the best interests of the company and its shareholders as a whole, without any involvement from stakeholders in the decision-making process.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company has established an adequate internal control system appropriate to its business operations. The Internal Auditor is responsible for assessing deficiencies in the Company’s internal controls by systematically reviewing accounting processes and operational procedures. The Internal Auditor prepares reports on the effectiveness of internal controls and presents them to the relevant management to formulate future action plans. In addition, the Internal Auditor meets regularly with the Audit Committee to report audit results.
The Audit Committee is responsible for ensuring that any identified internal control deficiencies are properly addressed, corrected, and prevented in an efficient manner and within an appropriate timeframe.
Furthermore, the Company has implemented measures and preventive guidelines against fraud and misconduct in accordance with its regulations, including established procedures for receiving complaints and whistleblowing reports, as well as providing protection to whistleblowers in line with its corporate governance policy.
Form of Anti-Corruption Operations
| Operation |
|---|
| Review of the completeness and adequacy of the process by the Audit Committee or auditor |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
No
Operations in the Past Year
None
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
0
Rights of Minority Shareholders on Director Appointment
Corporate Governance Policy
The Board of Directors is committed to promoting the Company to be an efficient organization in business operations, corporate governance, and excellent management by focusing on creating maximum benefits for shareholders and taking into account all stakeholders, having business ethics, transparency, and accountability. It has established a good corporate governance policy for the Board of Directors, executives, and employees to adhere to as guidelines for their work, which has important principles of good corporate governance in shareholder rights as follows:
1. Right to attend the Shareholders’ Meeting. The Company grants the right to all shareholders, including institutional investors, to attend the Shareholders’ Meeting, both the Annual General Meeting and the Extraordinary General Meeting, and to vote separately on each agenda item proposed and separately on each item in the event that the agenda item has multiple items, including the ability to grant a proxy to another person to attend the meeting and vote on their behalf. ***At the 2025 Annual General Meeting of Shareholders, Salee Printing Public Company Limited held the meeting on April 24, 2025, at 09.00 a.m. at the Grand Ballroom, Salee Printing Public Company Limited.
2. Right to receive dividends/profit. The Company has a policy to pay dividends to shareholders at a rate of not less than 30 percent of the net profit after corporate income tax each year. However, the payment of dividends each year shall take into account the following factors, such as the Company’s operating results and financial position, the Company’s liquidity, business expansion, and other relevant factors in the Company’s management. The payment of dividends as mentioned above must be approved by the Board of Directors and the Shareholders’ Meeting, respectively.
3. The right to propose an agenda for the Company’s meeting provides an opportunity for minority shareholders to propose an agenda for the Annual General Meeting of Shareholders by notifying in advance through the information system of the Stock Exchange of Thailand and the Company’s website. ***In order to allow minority shareholders to have the right to propose an agenda for the Annual General Meeting of Shareholders and persons in advance at the 2025 Annual General Meeting of Shareholders for consideration for election as directors of the Company between November 20, 2025, and December 30, 2025.
Sending of Notice of Meeting. The Company shall send a notice of meeting stating the place, date, time, agenda, and matters to be proposed to the meeting to shareholders not less than 7 days before the meeting and advertise in a newspaper for 3 consecutive days not less than 3 days before the meeting date, including publishing such notice of meeting on the Company’s website not less than 30 days before the meeting date to allow shareholders to have sufficient time to study the meeting materials in advance.
4. The right to elect and determine the remuneration of the Board of Directors. According to the Company’s Articles of Association, at each Annual General Meeting of Shareholders, one-third (1/3) of the directors shall retire from office, and directors shall be elected to replace the directors who retire by rotation. The retiring directors may be re-elected. Shareholders have the right to vote for directors according to the following criteria and procedures:
(1) Each shareholder shall have one vote for each share held.
(2) Each shareholder must use all of their votes according to (1) to elect one or more persons as directors, but may not divide the votes among any person. In addition, the Company grants shareholders the right to consider approving remuneration for directors at each Annual General Meeting of Shareholders.
5. The right to express opinions and ask questions to the Company’s meeting provides an opportunity for shareholders to submit questions in advance before the meeting date by setting criteria and informing shareholders along with sending the notice of meeting and publishing it on the Company’s website. All members of the Board of Directors, including the subcommittees and the Company Secretary, should attend the shareholders’ meeting to answer questions, listen to the opinions of shareholders, and record them in the minutes of the shareholders’ meeting.
6. Facilitating Shareholders. The Company arranges the venue for the shareholders’ meeting to be large enough to accommodate the number of shareholders, convenient for travel, and uses a computer system to assist in registration at the meeting, including the method of counting votes by collecting the voting cards of shareholders and having at least 2 independent persons as scrutineers at the meeting, as well as disclosing the voting results to the meeting and disclosing them through the information system of the Stock Exchange of Thailand and the Company’s website.
Equitable Treatment of Shareholders
1. One share, one vote. Shareholders have the right to attend and vote at the shareholders’ meeting, whereby each shareholder has one vote for each share held. Any shareholder who has a special interest in any matter shall not be entitled to vote on that matter. The Company shall inform the shareholders of the voting procedures before proceeding with the agenda.
2. Nomination of persons to serve as directors of the Company. The Company provides an opportunity for shareholders to nominate persons to serve as directors at the Annual General Meeting of Shareholders by setting criteria and procedures for nomination and notifying in advance through the information system of the Stock Exchange of Thailand, including the Company’s website. www.saleeprinting.com or by email. secretary@saleeprinting.com in advance (November of every year).
3. Providing Form A, Form B, and Form C proxy forms. The Company provides Form A, Form B, and Form C proxy forms for the 2025 Annual General Meeting of Shareholders, which are forms that specify the various items that can be proxied in detail, clearly, and cannot be changed so that shareholders can determine the direction of voting on each issue, whether they agree, disagree, abstain, and separate so that shareholders can exercise their right to vote for directors individually in the agenda of the election of directors. The Company proposes the names of 3 independent directors as an option for shareholders to grant a proxy. The Company has determined that the independent directors consist of
1) Pol.Maj.Gen Turdsak Rujiravong : Independent Director / Chairman
2) Mrs. Warangkana Kalyanapradit : Audit Committee and Independent Director / Nomination and
Remuneration Committee
4. Providing meeting-related documents in English for foreign shareholders. The Company provides meeting-related documents in English for foreign shareholders and makes the same documents available on the Company’s website prior to the shareholders’ meeting.
5. The policy on the protection of the Company’s inside information is the responsibility of the Directors and Executives to strictly maintain the confidentiality of the Company’s information, especially inside information that has not yet been disclosed to the public or information that may affect business operations or share prices. The use of material inside information must be carried out appropriately, taking into account the impact on stakeholders as a whole and the correctness as prescribed by law, and must not use such information for personal gain or for the benefit of others. The Company has established guidelines for practice in the Code of Conduct of Salee Printing Public Company Limited to ensure that the performance of the Board of Directors, executives, and employees of the Company is standardized, consisting of morality and ethics for the benefit of stakeholders, shareholders, and society. In addition, the Company has informed the Board of Directors and executives of their duty to report the holding of securities of the Company, both of themselves, their spouses, and their unemancipated children, to the Office of the Securities and Exchange Commission (SEC) in the event of a change in shareholding due to the purchase, sale, transfer, or receipt of securities within 3 business days from the date of the transaction, including penalties under the Securities and Exchange Act B.E. 2535. If there is a change in the holding of such securities, the Company will report to the Office of the Securities and Exchange Commission (SEC). The Company also requires that the shareholding information of the Board of Directors and executives be reported to the Board of Directors meeting every quarter.
6. The policy regarding the trading of securities of the Company, executives, and permanent employees of the Company, including their spouses and unemancipated children, prohibits related persons from trading in the Company’s securities or transferring the Company’s shares, whether directly or indirectly (e.g., Nominee through a private fund) during the period of 1 month before the disclosure of financial statements to the Stock Exchange of Thailand and within 3 days after the disclosure of financial statements to the Stock Exchange of Thailand) to allow shareholders and investors to have sufficient time to access and understand the essence of the Company’s news and information or financial statements disclosed to the Stock Exchange of Thailand.
7. Policy on Directors’ Interest in Considering Agenda Items. At a meeting of the Board of Directors, if any director has an interest or a conflict of interest in an agenda item under consideration, such director shall not participate in the meeting and abstain from voting on such agenda item.
8. Conflict of Interest Prevention. The Company considers it an important policy that directors, executives, and employees do not take advantage of being a director, executive, or employee of the Company to seek personal gain and must try to avoid conflicts of interest that may affect decision-making. In performing their duties, they must uphold the interests of the Company under the law and ethics. To prevent the problem of conflicts of interest, the Company has established guidelines for executives and employees to adhere to as follows:
(1.) Avoid engaging in self-dealing that may create a conflict of interest with the Company.
(2.) In the event that an executive or employee has entered into a connected transaction with the Company, the Company will treat it as if the Company had transacted with an outside person, and such executive or employee must not participate in the approval consideration.
(3.) Do not use the opportunity or information obtained from being an executive or employee to seek personal gain and in doing business that competes with the Company or doing related business.
(4.) Do not use inside information for their own benefit in trading the Company’s shares or provide inside information to others for the benefit of trading the Company’s shares.
(5.) In the case of holding any position in other companies or business organizations, it must not conflict with the interests of the Company and the direct performance of duties in the Company. It must be notified to the highest level executive.
(6.) While working for the Company and after leaving the Company, employees must not disclose information that is considered confidential to the Company for the benefit of anyone, whether it is electronic information, financial information, operational information, business information, future plans of the Company, etc. If there is a transaction that may have a conflict of interest, the Audit Committee will consider and present it to the Board of Directors for acknowledgment of the transaction with a conflict of interest, a connected transaction, which the Board of Directors has carefully considered the appropriateness of each time, including compliance with the regulations of the Stock Exchange and disclosing details, transaction value, counterparties, reasons, and necessity in the annual report and Form 56-1, as well as in the notes to the financial statements.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
Qualifications of Independent Directors
Independent Director means a person who has the qualifications as prescribed by the Board of Governors of the Securities and Exchange Commission, according to the Notification of the Board of the Capital Market Supervisory Board No. Tor Jor. 4/2552 Re: Application for and Approval of the Offering of Newly Issued Shares (No. 2) and its amendments. The Company has defined the definition of an independent director as follows:
(1) Hold no more than one percent (1%) of the total voting shares of the Company, its parent company, subsidiary, associated company, major shareholder, or person who has control of the Company, including the shareholding of the related person of such independent director.
(2) Not be or have ever been a director, executive, employee, consultant who receives a regular salary, or person who has control of the Company, its parent company, subsidiary, associated company, subsidiary of the same level, major shareholder, or person who has control of the Company, unless such person has ceased to hold such position for at least two years prior to the date of submitting the application to the Office. However, such prohibited characteristics do not include the case where the independent director was a government official or advisor to a government agency that is a major shareholder or person who has control of the Company.
(3) Not be a person who has a relationship by blood or registration under the law in the nature of father, mother, spouse, sibling, and child, including the spouse of a child, of another director, executive, major shareholder, person who has control, or person who is proposed to be a director, executive, or person who has control of the Company or its subsidiaries.
(4) Have no or have never had a business relationship with the Company, its parent company, subsidiary, associated company, major shareholder, or person who has control of the Company in a manner that may interfere with the exercise of their independent judgment, including not being or having ever been a significant shareholder or person who has control of a person who has a business relationship with the Company, its parent company, subsidiary, associated company, major shareholder, or person who has control of the Company, unless such person has ceased to hold such position for at least two years prior to the date of submitting the application to the Office. The aforementioned business relationship includes normal trade transactions for the purpose of carrying on business, lease or rental of immovable property, transactions relating to assets or services, or the giving or receiving of financial assistance by way of borrowing or lending, guaranteeing, providing assets as security for debts, including other similar acts, which result in the Company or the counterparty having a liability to pay to the other party of at least three percent of the net tangible assets of the Company or at least twenty million baht, whichever is lower. The calculation of such liabilities shall be in accordance with the method of calculating the value of connected transactions under the Notification of the Capital Market Supervisory Board on the Rules on Connected Transactions, mutatis mutandis. However, in considering such liabilities, liabilities incurred during the one year period prior to the date of having a business relationship with the same person shall be included.
(5) Not be or have ever been an auditor of the Company, its parent company, subsidiary, associated company, major shareholder, or person who has control of the Company, and not be a significant shareholder, person who has control, or partner of an audit firm of which an auditor of the Company, its parent company, subsidiary, associated company, major shareholder, or person who has control of the Company is a member, unless such person has ceased to hold such position for at least two years prior to the date of submitting the application to the Office.
(6) Not be or have ever been a provider of any professional services, including legal or financial advisory services, who has received a service fee of more than two million baht per year from the Company, its parent company, subsidiary, associated company, major shareholder, or person who has control of the Company, and not be a significant shareholder, person who has control, or partner of such professional service provider, unless such person has ceased to hold such position for at least two years prior to the date of submitting the application to the Office.
(7) Not be a director appointed to represent a director of the Company, a major shareholder, or a shareholder who is related to a major shareholder.
(8) Not engage in any business that is of the same nature and in significant competition with the business of the Company or its subsidiaries, or be a significant partner in a partnership, or be a director, executive, employee, consultant who receives a regular salary, or hold more than one percent of the total voting shares of another company that engages in any business that is of the same nature and in significant competition with the business of the Company or its subsidiaries.
(9) Have no other characteristics that would prevent them from providing independent opinions on the Company's operations.
Term of Office
The term of office of the Company's directors is determined in accordance with the Public Limited Company Act B.E. 2535, i.e., at the annual general meeting of shareholders, one-third of the directors shall retire from office, with the director who has been in office the longest being the one to retire. Directors who retire by rotation may be re-elected to office by a majority vote of the Nomination and Remuneration Committee or a resolution of the shareholders' meeting.
In this regard, “Independent Directors” can serve a consecutive term of no more than 9 years from the date of their first appointment as an independent director. In the case of appointing an independent director to continue in office, i.e., receiving a unanimous resolution from the Nomination and Remuneration Committee that such director has made significant contributions to the Company and that serving beyond the specified term will not affect their independence, it must also be approved by the Board of Directors and the shareholders of the Company.
Did Any Independent Director Have a Business or Professional Relationship?
No
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
According to good corporate governance for listed companies, the Board of Directors and subcommittees should conduct a self-evaluation at least once a year. The evaluation should be conducted both as a group and individually, covering 6 topics as follows:
Individual Board Self-Assessment Form
Board of Directors’ Self-Assessment Form (Collective)
Audit Committee Self-Assessment Form (Collective)
Nomination and Remuneration Committee Self-Assessment Form (Collective)
Rating Criteria
0 Strongly disagree / Not implemented
1 Disagree / Slightly implemented
2 Agree / Moderately implemented
3 Moderately agree / Well implemented
4 Strongly agree / Excellently implemented
Evaluation of Board Performance in the Past Year
Summary of the Performance Evaluation of the Nomination and Remuneration Committee (Collective) for the Year 2025 (B.E. 2568)
The self-assessment was completed by all 3 committee members, covering 3 evaluation topics. The summary results are as follows:
Evaluation Topics | Strongly Agree | |
1. Board structure and qualifications | 100% | |
2. Effectiveness of subcommittee meetings | 100% | |
3. Roles, duties, and responsibilities of the committee | 100% | |
Summary of the Self-Assessment of the Audit Committee (Collective) for the Year 2025 (B.E. 2568)
The self-assessment was completed by all 3 committee members, covering 3 evaluation topics. The summary results are as follows:
Evaluation Topics | Strongly Agree | |
1. Board structure and qualifications | 100% | |
2. Effectiveness of subcommittee meetings | 100% | |
3. Roles, duties, and responsibilities of the committee | 100% | |
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance | ||||||||
|---|---|---|---|---|---|---|---|---|
Results of the Self-Assessment of the Nomination and Remuneration Committee (Collective) for the Year 2025 (B.E. 2568) Summary of the Self-Assessment Results of the Nomination and Remuneration Committee (Collective) for the Year 2025 (B.E. 2568) The self-assessment was completed by all three committee members and covered three evaluation topics. The summary of the collective self-assessment results of the Nomination and Remuneration Committee is as follows:
|
Meeting Attendance & Remuneration
Justification for Directors' Non-Attendance
Regarding the Board of Directors meetings in 2025, the following directors will be unable to attend:
Mr. Suchat Boonbanjedsrii, Position: Director and Independent Director, was unable to attend 1 meeting due to overseas travel commitments.
Mr. Sathit Tatawatorn, Position: Director, was unable to attend 1 meeting due to domestic travel commitments.
Types of Remuneration of the Board of Directors
The remuneration for the 10 directors of the Company is summarized below:
1. Meeting allowance for all 3 committees for the year 2025
(1) Board of Directors Meeting Allowance - Chairman of the Board 35,000 Baht per session - Director 30,000 Baht per session
(2) Audit Committee Meeting Allowance - Chairman of the Committee 25,000 Baht per session - Member 20,000 Baht per session
(3) Meeting allowance for the Nomination and Remuneration Committee - Chairman of the Committee 15,000 Baht per session - Member 10,000 Baht per session
2. Director's Remuneration Total for the entire committee not exceeding 3,000,000 Baht per year.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
No
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
No
Mechanism for Overseeing Management of Subsidiaries
1. Intercompany Transactions
Persons Potentially Having Conflicts of Interest
1. Salee Industry Public Company Limited Relationship: Parent company of the Company, holding 65% of the total issued and sold shares of the Company.
As of February 3, 2016
2. Salee Colour Public Company Limited Relationship: V.I.V. Interchem holds 21.12% of the shares, Salee Industry Public Company Limited holds 8.17% of the shares, and has a common director, Mr. Suchart Chivaphornthip.
3. Petch Siam (Thailand) Co., Ltd. Relationship: Salee Industry holds 75.5% of the shares and has a common director, Mr. Satit Tatvathorn.
4. Bongkot Kaeo (Thailand) Co., Ltd. Relationship: Petch Siam holds 100% of the shares and has a common director, Mr. Satit Tatvathorn.
5. Three Bond Car Detailing Co., Ltd. Relationship: Three Bond V.I.V. Sales holds 100% of the shares. V.I.V. holds 51% of the shares in Three Bond V.I.V. Sales.
Common director is Mr. Suchart Chivaphornthip.
6. V Two V Co., Ltd. Relationship: V.I.V. holds 99.99% of the shares and has a common director, Mr. Praphut Chivaphornthip.
7. V.I.V. Interchem Co., Ltd. Relationship: V.I.V. holds 2.96% of the shares.
8. Vita Co., Ltd. Relationship: V.I.V. jointly holds shares in Vita Co., Ltd.
9. Three Bond V.I.V. Sales (Thailand) Co., Ltd. Relationship: V.I.V. jointly holds shares in Three Bond V.I.V. Sales (Thailand) Co., Ltd.
10. Dr. Prapol Chiwapornthip He is the son of Mr. Pracha Chiwapornthip and the younger brother of Mr. Prabhut Chiwapornthip. He holds 0.15% of the company's shares. The company pays Dr. Prapol Chiwapornthip consulting fees according to the contract, which is for a period of one year, from October 2025 to September 2027 (renewal possible as resolved at the Board of Directors meeting No. 2/2025 on August 11, 2025).
2. Procedures or Steps for Approving Intercompany Transactions
In the event that the Company's intercompany transactions occur with persons who may have a conflict of interest, have an interest, or may have a conflict of interest in the future, the Company shall have the Audit Committee provide an opinion on the necessity and appropriateness of such transactions after the occurrence of the transactions in each quarter. In the event that the Audit Committee does not have expertise in considering the intercompany transactions that may occur, the Company shall have an independent expert or the Company's auditor provide an opinion on such intercompany transactions before the Audit Committee provides an opinion on the necessity and appropriateness of such transactions for use in the decision-making of the Board of Directors or shareholders, as the case may be. At the meeting of the Board of Directors or shareholders to approve the transaction, persons who may have a conflict of interest and have an interest shall not be entitled to vote.
3. Policy and Future Intercompany Transactions
• Normal business transactions and transactions supporting normal business with general commercial terms, such as the purchase or sale of goods and services, etc. The Company has established a policy for intercompany transactions to have various terms and conditions in accordance with the nature of normal business practices at market prices, which are comparable to prices charged to outside parties, and to comply strictly with the agreements entered into. The Company shall also clearly and fairly determine the prices and terms of the transactions and shall not result in the transfer of benefits. The Internal Audit Department will be responsible for reviewing the information and preparing a report for the Audit Committee to consider and provide an opinion on the appropriateness of the prices and the reasonableness of the transactions on a quarterly basis.
• Normal business transactions and transactions supporting normal business without general commercial terms and other intercompany transactions, such as the acquisition or disposal of assets and the receipt or provision of financial assistance, such as loans, guarantees, and the use of assets as collateral, etc. The Company has a policy for the Audit Committee to consider and provide an opinion on the reasonableness and necessity of the transactions before entering into the transactions and must comply with the Securities and Exchange Act and the rules, announcements, orders, or regulations of the Securities and Exchange Commission. This includes compliance with the requirements for disclosure of connected transactions and the acquisition or disposal of major assets of the Company or its subsidiaries. The directors shall not be entitled to vote to approve any transaction in which they or any person who may have a conflict of interest has any interest in such transaction, including disclosing the nature of the relationship and the details of such transaction to the Board of Directors for consideration. In addition, in the event that the Audit Committee does not have expertise in considering such intercompany transactions, the Company shall have an independent expert provide an opinion on such intercompany transactions for use in the decision-making of the Board of Directors or shareholders, as the case may be. The Board of Directors shall comply with the Securities and Exchange Act and the rules, announcements, orders, or regulations of the Office of the Securities and Exchange Commission, the Stock Exchange of Thailand, including compliance with the requirements for connected transactions and the acquisition or disposal of major assets of the Company or its subsidiaries, to ensure that the decision to enter into such transactions does not create a conflict of interest and is in the best interests of all shareholders. In addition, the Company will disclose such intercompany transactions in the Annual Information Form (Form 56-1), the Company's Annual Report, and the notes to the financial statements audited by the Company's auditor.
Oversight Mechanisms
| Mechanism |
|---|
| Transactions between the Company and related persons |
| Disclosure of financial information and operating results |
Agreements Between the Company and Shareholders in Managing Subsidiaries
Governance of Subsidiaries and Associated Companies
As of December 31, 2025, the Company did not have any investments in subsidiaries or associated companies. Therefore, there was no establishment of policies for governing the operations of subsidiaries and associated companies.
Board Duty Performance — Overview
Board Duty Performance — Overall Description
Summary of the Performance Evaluation of the Board of Directors for the Year 2025 (B.E. 2568)
In accordance with the principles of good corporate governance for listed companies, it is recommended that the Board of Directors and its subcommittees conduct a self-assessment at least once a year. This enables the Board to collectively review its performance and identify areas for improvement. The evaluation should be conducted both on a collective (board-level) and individual basis. To promote and support continuous annual assessments of subcommittees, the Company arranged for the Board of Directors to complete the performance evaluation for the year 2025 (B.E. 2568), categorized into four types as follows:
Summary of the Self-Assessment of the Board of Directors (Individual) for the Year 2025 (B.E. 2568)
The self-assessment was completed by 3 directors, covering 3 evaluation topics. The summary results are as follows:
Evaluation Topics | Agree | Strongly Agree | |
1. Board structure and qualifications | 10% | 90% | |
2. Effectiveness of subcommittee meetings | 10% | 90% | |
3. Roles, duties, and responsibilities of the committee | 10% | 90% | |
Summary of the Self-Assessment of the Board of Directors (Collective) for the Year 2025 (B.E. 2568)
The self-assessment was completed by all 10 directors, covering 6 evaluation topics. The summary results are as follows:
Evaluation Topics | Agree | Strongly Agree | |
1.Board structure and qualifications | 10% | 90% | |
2.Roles, duties, and responsibilities of the Board | 10% | 90% | |
3.Board meetings | 10% | 90% | |
4.Performance of the Board | 10% | 90% | |
5.Relationship with management | 10% | 90% | |
6.Directors’ self-development and executive development | 10% | 90% | |
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
Summary of the Performance Evaluation of the Nomination and Remuneration Committee (Collective) for the Year 2025 (B.E. 2568)
The self-assessment was completed by all 3 committee members, covering 3 evaluation topics. The summary results are as follows:
Evaluation Topics | Strongly Agree | |
| 100% | |
| 100% | |
| 100% | |
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
The Company has clearly defined the roles, duties, and responsibilities of the management. An Executive Committee has been established, with the Chief Executive Officer serving as the head and leader of the Company’s management team in overseeing the administration of the Company. The scope of responsibilities includes the following:
Managing and supervising the Company’s operations in relation to general administration to ensure alignment with the Company’s objectives, policies, rules, and regulations.
Considering investment plans in various businesses and proposing them to the Executive Committee and the Board of Directors for further consideration and approval.
Having the authority to enter into juristic acts binding upon the Company within the scope specified in the Company’s policies and authorization procedures.
The delegation of authority, duties, and responsibilities to the Chief Executive Officer shall not constitute a delegation or sub-delegation of authority that would enable the Chief Executive Officer or any person authorized by the Chief Executive Officer to approve transactions in which they or any person who may have a conflict of interest has an interest or may have any other form of conflict of interest with the Company.
This exclusion does not apply to the approval of transactions that are in accordance with the policies and criteria previously approved by the Board of Directors. Any such transactions must be proposed to the Board of Directors’ meeting and/or the Shareholders’ Meeting for consideration and approval in compliance with the regulations of the Stock Exchange of Thailand, the Office of the Securities and Exchange Commission (SEC), or other applicable laws.
